Member Info for BasilAlderman

With a successful EWT 1.6p today could be x 10 at 16p within weeks based on what we know already:

1. "Near-continuous helium and hydrogen shows were encountered whilst drilling. The frequency of these shows continued to TD and were notably higher than those which were encountered whilst drilling the overburden section during Phase II".

2. There's 138 billion cubic feet (bcf) of unrisked prospective recoverable Helium Resource in Rukwa, making it the largest known primary helium deposit in the world.

3. Global major players in the helium sector will already be up to speed on the HE1 discovery.

4. HE1 have also said in its recent RNS of July 1st, 2024, that "helium concentrations that were brought to surface could be slightly higher than previously thought".

In summary, this could be even bigger than most have been predicting. i.e. 16p a share is not unreasonable when you factor in that GGP became a £Billion pound company for a while on the back of its big news as did RKH. Plus as others have pointed out just look at ARB to see what momentum in a share price can deliver for the astute investor. HE1 is certanly at the tipping point where a x 10 could happen quite quickly on the back of positive news. i.e. 1.6p today could be 16p within weeks

Yes, a key player could swoop in and buy out HE1. Candidates could include Exxon ($503 Billion Mcap) in addition to Air Liquide (102 Billion Mcap). Both could be in the frame for a JV / MOU with HE1 for the helium discovery at the Itumbula West-1 well . All the major players are going to be fully up to speed regarding HE1's statement that helium is flowing to the surface in "such significant concentrations" and that this "has confirmed a globally unique helium producing province". HE1 is big news in our industry and there won't be many CEO's in this space unaware of the helium levels that have been found at Itumbula. Just watch this share price rocket when we get the EWT news followed by JV or M&A news. e.g. GGP went from below 0.60p a share to over 30p a share.

Yes, quite right. A £1.3 Billion MCAP would be cheap for a worldwide helium discovery of this magnitude. It's worth reminding everyone that HE1 have also said in its recent RNS of July 1st, 2024, that "helium concentrations that were brought to surface could be slightly higher than previously thought". In summary, this could be even bigger than most have been predicting. i.e. 25p a share is not unreasonable when you factor in that GGP became a £Billion pound company for a while on the back of its big news as did RKH. Plus as others have pointed out just look at ARB to see what momentum in a share price can deliver for the astute investor. HE1 is certanly at the tipping point where a x 10 could happen quite quickly on the back of positive news.

Yes, both KoBold and now First Quantum backing TYM with JV's is not to be sniffed at. i.e. This is clearly another exciting development for TYM and its shareholders.

James Cheek's next move could be interesting. To put this into some context when Lookers plc bought out Benfield Group Nigel McMinn, Lookers Managing Director, was previously Benfield's Chief Executive. i.e. he knew his previous company and the value attached to it. In summary, it is not unheard of for a CEO to leave because he is part of a rival bid or that he joins another company and within a year, as in the Lookers example above, he comes back to buy it. This is an interesting and unexpected development today and one to keep a close eye on.

Boom alright! "Near-continuous helium and hydrogen shows were encountered whilst drilling. The frequency of these shows continued to TD and were notably higher than those which were encountered whilst drilling the overburden section during Phase II".

Yes Rambo, we are in the right share, in the right sector at the right time. According to the actual data there's 138 billion cubic feet (bcf) of unrisked prospective recoverable Helium Resource in Rukwa, making it the largest known primary helium deposit in the world. That is why global major players in the helium sector will already be up to speed on the HE1 discovery and will be making plans to takeover or sign a JV deal with HE1. When that happens we are looking at a massive re-rate akin to Toffers 40p a share prediction.

Yes, it does look like HE1 is heading to 3p+ a share soon. Ofcourse if we get a barnstorming EWT update followed by a JV with a major player then 3p will be more like 30p a share. Just look at PPP and its x 20 last month.

GDR estimates the market for this is worth in excess of £100 million per annum. Remind me what our current MCAP is?! This is massive news today.

Has anyone said "BOOM" yet! Let me be the first. Come on GDR lets see a PPP X 20 "Mega Multi Bagger" over the coming weeks and months.

You have to ask yourself which major pharma isn't going to want to buy GDR now that the CYP2C19-ID test has been given the green light by NICE? The number of strokes globally is growing each year and big pharma will want a piece of the £100 Million revenue action.

The UK Stroke Association figures are:

1. A stroke strikes every five minutes in the UK

2. 100,000 people in the UK have strokes each year

That's a lot of potential tests for GDR's CYP2C19 ID stroke kit in the UK alone and then you add the rest of the world at 77 million strokes per year and you see the true potential of GDR for patients (and investors).

Yes a 100 Million MCAP in the pharma sector is cheap when you know that Ian Gilham, Chair of Genedrive, has a track record of selling his businesses for hundreds of millions of pounds (£250 Million for Axis-Shield & £300 Million for Horizon Discovery). i.e. daily share prie rises could go on for months on the back of multiple RNS announcements moving forward.

When momentum kicks in a share price can have an upwards trajectory for months. e.g. There are many examples of AIM plcs in our sector that have seen rises carry on for over a year. NCYT 12p to 1200p over 12 months. SAR 10p to 450p in 12 months. AVCT 20p to 250p in 12 months. SNG 8p to 250p in 12 months and yes even GDR going from 8p to 130p in 12 months a while back.

It looks like we might be at the start of a new GDR share price surge based on the previous GDR share price action:

1. GDR went from 9p to 173p in 3 months, between March 2020 and May 2020.

2. GDR also had a rapid climb from 41p to 146p in 2021

3. GDR went from 12p - 30p in March 2022.

4. Last year GDR soared from 8p to 32p on positive news.

We could be looking at 20p a share soonish on the back of this news. £100 Million revenues annually for the CYP2C19-ID test is huge, especially when you focus on the following:

1. 1 in 4 adults over the age of 25 will have a stroke in their lifetime.

2. Over 12 million people worldwide will have their first stroke this year

3. 6.5 million will die as a result of a stroke this year.

This is a HOLD for GOLD moment!

To see what could happen with the GDR share price now it would be prudent to take a glance over at PPP. In the last 2 weeks PPP has risen from 0.55p to 11p+. That's a x 20 Mega Multi-bag. GDR is on the launch pad to do the same in due course.

Anyone doubting the mega rise that could happen here with HE1 on the back of a positive EWT and then JV / MOU just needs to glance over at PPP. In the last 2 weeks PPP has risen from 0.55p to 11p+. That's a x 20 Mega Multi-bag.

Yes, 0.55p to 11p+ in 2 weeks for PPP. That's a x 20 Mega Multi-bag. i.e. These kind of mega gains do happen and it just goes to show you what could happen with TYM very soon.

Yes and available data shows that the unrisked Prospective Recoverable Helium Resource in Rukwa stands at 138 billion cubic feet (bcf), making this the largest known primary helium deposit in the world. That is why global major players in the helium sector will already be up to speed on the HE1 discovery and will be making plans to takeover or sign a JV deal with HE1. We are in the right share, in the right sector at the right time.

Yes, the shares that have performed best for me in my ISAs and Sipps are not to dissimilar to where GST is currently. e.g. Sareum went from similar levels to 9p. GGP, which I was invested in, is a classic example of 0.60 to 35p. Well worth the 2 year wait. ARB, another of my Mega Multi Baggers, climbed from 3.5p in 2020 to over 300p 12 months later. I'm just pointing out, before the brick bats come flying in (!), that sometimes it's worth investing for the long haul. GST could quite easily be 6.5p within a few months. By the way, 6.5p will be just for starters at £130 Million Mcap. This is much more likely to be valued in the hundreds of millions in the next 2-3 years.

Yes and don't forget that GDR went from 9p to 173p in 3 months, between March 2020 and May 2020. GDR also had a rapid climb from 41p to 146p in 2021 and GDR went from 12p - 30p in March 2022. Last year GDR soared from 8p to 32p on positive news. It looks like we might be at the start of a new GDR share price surge based on the previous GDR share price action.

Yes, 9p a share soon looks very doable - which is only a 100% gain from today. Then the NICE news could / should take it into double figures and maybe in to the 20p arena. There is such a huge global market for the CYP2C19-ID test when you focus on the following:

1. 1 in 4 adults over the age of 25 will have a stroke in their lifetime.

2. Over 12 million people worldwide will have their first stroke this year

3. 6.5 million will die as a result of a stroke this year.

4. Over 77 million people in the world have experienced an ischaemic stroke in the last year. This number is growing year on year.

You have to ask yourself which major pharma isn't going to want to buy GDR once the CYP2C19-ID test is given the green light by NICE? The number of strokes globally is growing each year and big pharma will want a piece of the action.